Popular New
- Trends in the delivery of care to oncology patients in the United States: Emphasis on the role pharmacists on the healthcare team537 daysJournal of Oncology Pharmacy PracticeRead
- Does equipment change impact blood contamination with irinotecan and its two major metabolites in a centralized cytotoxic pharmacy unit?572 daysJournal of Oncology Pharmacy PracticeRead
- Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol572 daysJournal of Oncology Pharmacy PracticeRead
- 5-Fluorouracil degradation rate as a predictive biomarker of toxicity in breast cancer patients treated with capecitabine572 daysJournal of Oncology Pharmacy PracticeRead
- Comparison of eight screening tools to detect interactions between herbal supplements and oncology agents572 daysJournal of Oncology Pharmacy PracticeRead
- Intravenous lidocaine affects oxaliplatin pharmacokinetics in simultaneous infusion572 daysJournal of Oncology Pharmacy PracticeRead
- The effect of gemcitabine, dexamethasone, and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience572 daysJournal of Oncology Pharmacy PracticeRead
- Quantification of healthcare workers’ exposure to cyclophosphamide, ifosfamide, methotrexate, and 5-fluorouracil by 24-h urine assay: A descriptive pilot study572 daysJournal of Oncology Pharmacy PracticeRead
- Development and implementation of an electrolyte replacement protocol in the outpatient oncology infusion centers of a large academic healthcare system572 daysJournal of Oncology Pharmacy PracticeRead
- Expansion of pharmacist practice in oral oncolytic therapy with a collaborative practice agreement572 daysJournal of Oncology Pharmacy PracticeRead
- Stability studies of parenteral nutrition with a high dose of vitamin C572 daysJournal of Oncology Pharmacy PracticeRead
- Managing chemotherapy-related toxicities in the community setting: A survey of pharmacists in Ontario572 daysJournal of Oncology Pharmacy PracticeRead
- Toxicity profile of Doxorubicin-Cyclophosphamide and Doxorubicin-Cyclophosphamide followed by Paclitaxel regimen and its associated factors among women with breast cancer in Ethiopia: A prospective cohort study572 daysJournal of Oncology Pharmacy PracticeRead
- Cross-sectional evaluation of surface contamination with 9 antineoplastic drugs in 93 Canadian healthcare centers: 2019 results572 daysJournal of Oncology Pharmacy PracticeRead
- Application of KW-ANOVA statistics to generate evidence for cytotoxic drug wastage induced financial burden among cancer patients: A clinical pharmacist observation616 daysJournal of Oncology Pharmacy PracticeRead
- Intraperitoneal paclitaxel and cisplatin compared with dose-dense paclitaxel and carboplatin for patients with stage III ovarian cancer616 daysJournal of Oncology Pharmacy PracticeRead
- Protective effect of N-acetylcysteine on oxaliplatin-induced neurotoxicity in patients with colorectal and gastric cancers: A randomized, double blind, placebo-controlled, clinical trial616 daysJournal of Oncology Pharmacy PracticeRead
- Neutrophil–lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)616 daysJournal of Oncology Pharmacy PracticeRead
- Evaluation of mobilization efficacy with an extended interval following plerixafor administration616 daysJournal of Oncology Pharmacy PracticeRead
- Assessment of the relationship between methylenetetrahydrofolate reductase polymorphism and acute lymphoblastic leukemia: Evidence from an updated meta-analysis616 daysJournal of Oncology Pharmacy PracticeRead
- The impact of tumor regression grade on long-term survival in locally advanced rectal cancer treated with preoperative chemoradiotherapy616 daysJournal of Oncology Pharmacy PracticeRead
- Toxicity, risk factors and management of cisplatin-induced toxicity: A prospective study616 daysJournal of Oncology Pharmacy PracticeRead
- Centralization impact and cost-saving study in a Moroccan hospital’s centralized unit of chemotherapy preparation616 daysJournal of Oncology Pharmacy PracticeRead
- Prospective evaluation of drug–drug interactions in ambulatory cancer patients initiated on prophylactic anticoagulation616 daysJournal of Oncology Pharmacy PracticeRead
- Evaluation of urinary neutrophil gelatinase-associated lipocalin and urinary kidney injury molecule-1 as biomarkers of renal function in cancer patients treated with cisplatin616 daysJournal of Oncology Pharmacy PracticeRead
- Evaluation of the efficacy and safety of apixaban and rivaroxaban in cancer patients receiving concomitant active anti-neoplastic therapy at an outpatient cancer setting616 daysJournal of Oncology Pharmacy PracticeRead
- The real-life outcome of pazopanib in patients with advanced soft tissue sarcoma: A retrospective cross-sectional study of a Turkish cohort616 daysJournal of Oncology Pharmacy PracticeRead
- Effectiveness of a pharmaceutical instruction video for adherence to dermatopathy treatment in patients with cancer receiving the anti-epidermal growth factor receptor antibody616 daysJournal of Oncology Pharmacy PracticeRead
- Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors616 daysJournal of Oncology Pharmacy PracticeRead
- Off-label infusion of biosimilar bevacizumab: A provincial experience616 daysJournal of Oncology Pharmacy PracticeRead
- Development of a tool to allocate inpatient specialized pharmacy resources at a comprehensive cancer center616 daysJournal of Oncology Pharmacy PracticeRead
- Role of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura616 daysJournal of Oncology Pharmacy PracticeRead
- Management of skin adverse reactions in oncology616 daysJournal of Oncology Pharmacy PracticeRead
- Continuous-infusion and outpatient setting: A chance for patients, a challenge for hospital pharmacists616 daysJournal of Oncology Pharmacy PracticeRead
- Optimizing care for high-risk neuroblastoma patients treated with dinutuximab: Challenges for the multidisciplinary team616 daysJournal of Oncology Pharmacy PracticeRead
- The pharmacist’s role in chimeric antigen receptor T cell therapy616 daysJournal of Oncology Pharmacy PracticeRead
- Suggestion of Tunisia’s medical oncologist in the management of breast cancer during COVID-19 pandemic616 daysJournal of Oncology Pharmacy PracticeRead
- Bruton’s tyrosine kinase inhibitors and the kidney: Focus on ibrutinib616 daysJournal of Oncology Pharmacy PracticeRead
- Steatohepatitis due to FOLFIRINOX regimen in adjuvant pancreas cancer treatment mimicking liver metastasis616 daysJournal of Oncology Pharmacy PracticeRead
- Advantages of everolimus therapeutic drug monitoring in oncology when drug–drug interaction is suspected: A case report616 daysJournal of Oncology Pharmacy PracticeRead
- Chemotherapy-induced pneumonitis associated with transient CA 15-3 elevation616 daysJournal of Oncology Pharmacy PracticeRead
- Treatment exceeds expectations with vemurafenib monotherapy in a patient with BRAFV600E-mutant metastatic melanoma616 daysJournal of Oncology Pharmacy PracticeRead
- Real-time comprehensive toxicology testing in the clinical management of accidental pediatric capecitabine ingestion616 daysJournal of Oncology Pharmacy PracticeRead
- Sweet’s syndrome under ipilimumab therapy and a brief comparison of the cases in literature616 daysJournal of Oncology Pharmacy PracticeRead
- Left ventricular dysfunction associated with axitinib and nivolumab experience in an advanced renal cell carcinoma616 daysJournal of Oncology Pharmacy PracticeRead
- Saddle pulmonary embolism with fluorouracil: A case report616 daysJournal of Oncology Pharmacy PracticeRead
- Autoimmune hypophysitis secondary to therapy with immune checkpoint inhibitors: Four cases describing the clinical heterogeneity of central endocrine dysfunction616 daysJournal of Oncology Pharmacy PracticeRead
- Safety of trastuzumab after trastuzumab emtansine-induced nodular regenerative hyperplasia: A case report616 daysJournal of Oncology Pharmacy PracticeRead
- Pegfilgrastim-associated large-vessel vasculitis developed during adjuvant chemotherapy for breast cancer: A case report and review of the literature616 daysJournal of Oncology Pharmacy PracticeRead
- Possible atezolizumab-associated acute kidney injury and immune thrombocytopenia616 daysJournal of Oncology Pharmacy PracticeRead
Quick Link
- Medicine - All Feeds
- Allergology and Immunology
- Anatomy and Physiology
- Anesthesiology and Intensive Care
- Biochemistry
- Bioengineering
- Biophysics
- Biotechnology
- Cardiology
- Cardiothoracic Surgery
- Clinical Chemistry
- Clinical Medicine
- Complementary Medicine
- Cytology and Histology
- Dentistry
- Dermatology
- Endocrinology
- Forensic Medicine
- Gastroenterology
- General Practice
- Genetics
- Geriatrics
- Health services and Administration
- Hematology
- Infectious Diseases
- Internal Medicine
- Logopedics
- Medical Education and Humanities
- Medical Microbiology
- Medicine - Other
- Nephrology
- Neurology
- Neurosurgery
- Nursing
- Nutritional Sciences
- Obstetrics and Gynecology
- Occupational Health
- Oncology
- Ophthalmology
- Oral and Maxillofacial Surgery
- Orthopedics and Traumatology
- Otorhinolaryngology and Phoniatrics
- Pathology
- Pediatrics
- Pharmacology and Pharmacotherapy
- Physical and Rehabilitation Medicine
- Plastic Surgery
- Psychiatry
- Psychology
- Public Health
- Radiology
- Respiratory Medicine
- Rheumatology
- Sports Medicine
- Surgery
- Urology